{"id":19091,"date":"2026-06-12T16:08:26","date_gmt":"2026-06-12T09:08:26","guid":{"rendered":"https:\/\/www.tibdglobal.com\/product\/encapsulation-systems\/"},"modified":"2026-10-01T16:02:54","modified_gmt":"2026-10-01T09:02:54","slug":"encapsulation-systems","status":"publish","type":"product","link":"https:\/\/www.tibdglobal.com\/en\/product\/encapsulation-systems\/","title":{"rendered":"Encapsulation Systems Stability Testing Service: From Microencapsulation to Nanoencapsulation"},"content":{"rendered":"
[vc_section][vc_row][vc_column][vc_column_text css=”” woodmart_inline=”no” text_larger=”no”]

The health and beauty industry uses Encapsulation Systems technology to solve three problems that open formulations cannot: Stability Protection of unstable active ingredients, Controlled Release, and Bioavailability Enhancement. Examples include encapsulating Vitamin C in microcapsules to prevent oxidation before skin contact, encapsulating Probiotics in coated capsules to survive stomach acid, and encapsulating essential oils in Liposomes to slow evaporation.<\/p>\r\n

The challenge is that encapsulation systems themselves are also unstable. The shell material may crack or degrade over time, Encapsulation Efficiency (EE%) decreases, the core material may leak prematurely, or the physical structure may deform, causing the Release Profile to deviate from its intended design. The business consequence is that the product cannot support the claims it was designed to make, fails registration, or faces questions from consumers and retailers.<\/p>\r\n

TIBD’s service covers custom stability testing protocol design for Encapsulation systems, analysis of Encapsulation Efficiency and Release Profile at pull points per ICH Q1A(R2) and the ASEAN Stability Guideline, and analysis conducted in partnership with VISBIO as an Independent Quality Assurance Verifier (IQAV) using Validated Methods per ICH Q2(R1), to provide data supporting FDA registration, Cosmetic Notification filing in ASEAN, and negotiations with international Brand Owners who use Encapsulation technology as a core selling point.<\/p>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column]\n\t\t

\n\t\t\t\n\t\t\t
\n\t\t\t\t

<\/span>What Is Encapsulation? Definition and Types of Delivery Systems<\/span><\/h4>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\n\t\t\t\n\t\t\t\n\t\t<\/div>\n\t\t\n\t\t[vc_column_text css=”” woodmart_inline=”no” text_larger=”no”]

Encapsulation is a technology that encloses a core material, such as bioactive compounds, vitamins, enzymes, live microorganisms (Probiotics), or essential oils, within a shell material that may be a polymer, lipid, protein, or carbohydrate.<\/p>\r\n

The three primary purposes of Encapsulation are: first, protecting the core material from degrading factors such as oxygen, light, moisture, heat, and extreme pH; second, Controlled Release so the core material is released at a specified time and location, such as intestinal rather than gastric release; and third, increasing Bioavailability by reducing particle size for improved absorption.<\/p>\r\n

Encapsulation types are categorized by particle size into Microcapsules (1-1000 micrometers) and Nanocapsules (below 1 micrometer); by structure into Reservoir Type, where a shell layer surrounds the core, and Matrix Type, where the core is distributed throughout the polymer matrix; and by material into Lipid-Based systems such as Liposomes and Solid Lipid Nanoparticles, Polymeric systems such as Microcapsules from Alginate, Chitosan, or Gelatin, and Protein-based systems such as Whey Protein Microspheres.<\/p>[\/vc_column_text][vc_single_image image=”18834″ img_size=”full” alignment=”center” css=”” parallax_scroll=”no” woodmart_inline=”no”][\/vc_column][\/vc_row][vc_row][vc_column]\n\t\t

\n\t\t\t\n\t\t\t
\n\t\t\t\t

<\/span>Differences Between Microencapsulation, Nanoencapsulation, and Liposome<\/span><\/h4>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\n\t\t\t\n\t\t\t\n\t\t<\/div>\n\t\t\n\t\t[vc_column_text css=”” woodmart_inline=”no” text_larger=”no”]

Manufacturers often use these terms interchangeably, but technically and from a regulatory standpoint, the differences are significant for both formulation design and stability testing protocols.<\/p>\r\n\r\n